Regulation of glucose kinetics during exercise by the glucagon-like peptide-1 receptor

被引:5
|
作者
Burmeister, M. A. [1 ]
Bracy, D. P. [2 ]
James, F. D. [2 ]
Holt, R. M. [1 ]
Ayala, J. [1 ]
King, E. M. [3 ]
Wasserman, D. H. [2 ]
Drucker, D. J. [4 ]
Ayala, J. E. [1 ,3 ]
机构
[1] Sanford Burnham Med Res Inst Lake Nona, Diabet & Obes Res Ctr, Metab Signaling & Dis Program, Orlando, FL 32827 USA
[2] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA
[3] Sanford Burnham Med Res Inst Lake Nona, Cardiometab Phenotyping Core, Orlando, FL 32827 USA
[4] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2012年 / 590卷 / 20期
基金
美国国家卫生研究院;
关键词
INSULIN-SECRETION; GLP-1; RECEPTORS; ENERGY-BALANCE; INCRETIN; METABOLISM; MICE; SUPPRESSION; SENSITIVITY; MUSCLE; AMIDE;
D O I
10.1113/jphysiol.2012.234914
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Key points Glucagon-like peptide-1 (Glp1) regulates hepatic glucose production (HGP) and muscle glucose uptake (MGU) via its ability to stimulate insulin secretion. Using exercise as a means to stimulate glucose flux independently of insulin secretion, we observed that Glp1 receptor (Glp1r) knockout (Glp1r-/-) mice become hyperglycaemic but display normal rates of MGU. Since euglycaemia during exercise is typically maintained by matching rates of HGP to rates of MGU, we hypothesize that exercise-induced hyperglycaemia in Glp1r-/- mice is due to excessive HGP. Using innovative catheterization and isotope dilution techniques, we demonstrate that hyperglycaemia in exercising Glp1r-/- mice is associated with excessive HGP and glucagon secretion. These results suggest an essential and novel role for basal Glp1r signalling in the suppression of alpha cell secretion during exercise. Abstract In response to oral glucose, glucagon-like peptide-1 receptor (Glp1r) knockout (Glp1r-/-) mice become hyperglycaemic due to impaired insulin secretion. Exercise also induces hyperglycaemia in Glp1r-/- mice. In contrast to oral glucose, exercise decreases insulin secretion. This implies that exercise-induced hyperglycaemia in Glp1r-/- mice results from the loss of a non-insulinotropic effect mediated by the Glp1r. Muscle glucose uptake (MGU) is normal in exercising Glp1r-/- mice. Thus, we hypothesize that exercise-induced hyperglycaemia in Glp1r-/- mice is due to excessive hepatic glucose production (HGP). Wild-type (Glp1r+/+) and Glp1r-/- mice implanted with venous and arterial catheters underwent treadmill exercise or remained sedentary for 30 min. [3-3H]glucose was used to estimate rates of glucose appearance (Ra), an index of HGP, and disappearance (Rd). 2[14C]deoxyglucose was used to assess MGU. Glp1r-/- mice displayed exercise-induced hyperglycaemia due to an excessive increase in Ra but normal Rd and MGU. Exercise-induced glucagon levels were 2-fold higher in Glp1r-/- mice, resulting in a 2-fold higher glucagon:insulin ratio. Since inhibition of the central Glp1r stimulates HGP, we tested whether intracerebroventricular (ICV) infusion of the Glp1r antagonist exendin(939) (Ex9) in Glp1r+/+ mice would result in exercise-induced hyperglycaemia. ICV Ex9 did not enhance glucose levels or HGP during exercise, suggesting that glucoregulatory effects of Glp1 during exercise are mediated via the pancreatic Glp1r. In conclusion, functional disruption of the Glp1r results in exercise-induced hyperglycaemia associated with an excessive increase in glucagon secretion and HGP. These results suggest an essential role for basal Glp1r signalling in the suppression of alpha cell secretion during exercise.
引用
收藏
页码:5245 / 5255
页数:11
相关论文
共 50 条
  • [1] Glucagon-like peptide-1 receptor
    Krashes, Michael
    CURRENT BIOLOGY, 2024, 34 (23) : R1163 - R1164
  • [2] Glucagon-like peptide-1 receptor is a regulator of glucose metabolism in oxidative tissues during exercise and is a determinant of exercise capacity
    Ayala, Julio E.
    Bracy, Deanna P.
    Drucker, Daniel J.
    Wasserman, David H.
    DIABETES, 2006, 55 : A234 - A234
  • [3] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
    De Block, Christophe E. M.
    Dirinck, Eveline
    Verhaegen, Ann
    Van Gaal, Luc F.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 788 - 805
  • [4] Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
    Underwood, Christina Rye
    Garibay, Patrick
    Knudsen, Lotte Bjerre
    Hastrup, Sven
    Peters, Gunther H.
    Rudolph, Rainer
    Reedtz-Runge, Steffen
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (01) : 723 - 730
  • [5] Glucagon-Like Peptide-1 Receptor Agonists
    Edelman, Steven V.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (10): : S12 - S16
  • [6] Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
    Ammann, Markus
    Santol, Jonas
    Pereyra, David
    Kalchbrenner, Tamara
    Wuerger, Tanja
    Laengle, Johannes
    Smoot, Rory L.
    Hulla, Wolfgang
    Laengle, Friedrich
    Starlinger, Patrick
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [7] Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
    Markus Ammann
    Jonas Santol
    David Pereyra
    Tamara Kalchbrenner
    Tanja Wuerger
    Johannes Laengle
    Rory L. Smoot
    Wolfgang Hulla
    Friedrich Laengle
    Patrick Starlinger
    Scientific Reports, 13
  • [8] The Glucagon-Like Peptide-1 Receptor-or Not?
    Pyke, Charles
    Knudsen, Lotte Bjerre
    ENDOCRINOLOGY, 2013, 154 (01) : 4 - 8
  • [9] Glucagon and glucagon-like peptide-1
    Livingston, JN
    Schoen, WR
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 189 - 198
  • [10] Glucagon-like peptide-1, glucose homeostasis and diabetes
    Holst, Jens J.
    Deacon, Carolyn F.
    Vilsboll, Tina
    Krarup, Thure
    Madsbad, Sten
    TRENDS IN MOLECULAR MEDICINE, 2008, 14 (04) : 161 - 168